![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Landen Pharmachem Nv Landen Be, based in Belgium, is a pharmaceutical company.
One of their significant offerings is Tilidine hydrochloride hemihydrate, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2008-260 - Rev 01
This Chemical Type CEP, issued on April 20, 2011, remains in force until January 14, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 1767 associated with this CEP further emphasizes